Serum levels of osteopontin –OPN (A), S-100β (B), and MIA (C) in gender and age-matched controls, patients who remained disease free ( DF) for at least 10 years after treatment for primary uveal melanoma, and patients who developed metastatic uveal melanoma to the liver.
* Represents a statistically different level of marker as compared to the other groups.